PHARMACYTE BIOTECH, INC. Preferred Stock Convertible Shares Issuable
PHARMACYTE BIOTECH, INC. (PMCB) had Preferred Stock Convertible Shares Issuable of 600.00 thousand shares as of 2025-09-30, per its 10-Q filed 2025-09-15.
Financial Statements › Notes › Equity › Features of Convertible Preferred Stock
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2025-09-15
- 2025-09-30: Preferred Stock Convertible Shares Issuable 600.00K shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2025-09-30 | 600.00K shares 10-Q · filed 2025-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |